:ocrelizumab

Fernando Rodríguez-Jorge1, José Ignacio Fernández-Velasco2, Noelia Villarrubia2

  • 1Neurology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Frontiers in immunology
|January 3, 2025
PubMed
概括

这项研究纠正了先前发表的一篇文章DOI. 校正确保准确的引用和参考,用于该领域的未来研究.